The Role of Clinical Studies for Pets with Naturally Occurring Tumors in Translational Cancer Research Workshop Summary (2015) / Chapter Skim
Currently Skimming:
Appendix A: Statement of Task
Appendix A: Statement of Task
Pages 57-58
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 57... ...
Participants will be invited to discuss topics that may include • An overview of the limitations of current preclinical oncology models and resulting late-stage drug development failures and costs; • Strategies to support the incorporation of data from clinical trials for pets with cancer in drug development pathways; • Gaps in the evidence base to support integration of such trials in the drug development continuum and ways to address those gaps; • Challenges and potential solutions to greater integration of such trials in cancer drug development pathways; and • Opportunities for further collaborations and information exchange between human and veterinary oncologists. The committee will develop the agenda for the workshop sessions, select and invite speakers and discussants, and moderate the discussions.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.